Julie Dewey
Investor Relations Kontakt bei ORTHOFIX MEDICAL INC.
Aktive Positionen von Julie Dewey
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ORTHOFIX MEDICAL INC. | Investor Relations Kontakt | 11.06.2024 | - |
Public Communications Contact | 11.06.2024 | - |
Karriereverlauf von Julie Dewey
Ehemalige bekannte Positionen von Julie Dewey
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NEVRO CORP. | Investor Relations Kontakt | 01.11.2020 | 01.07.2023 |
Public Communications Contact | 01.11.2020 | 01.07.2023 | |
WRIGHT MEDICAL GROUP N.V. | Public Communications Contact | 01.10.2011 | 01.11.2020 |
Kyphon, Inc. | Public Communications Contact | 01.04.2005 | 01.11.2007 |
TREACE MEDICAL CONCEPTS, INC. | Investor Relations Kontakt | 17.07.2023 | - |
Public Communications Contact | 17.07.2023 | - |
Ausbildung von Julie Dewey
University of Southern California | Undergraduate Degree |
Pepperdine University | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 7 |
Niederlande | 2 |
Operativ
Public Communications Contact | 5 |
Investor Relations Contact | 3 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
NEVRO CORP. | Health Technology |
TREACE MEDICAL CONCEPTS, INC. | Health Technology |
ORTHOFIX MEDICAL INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Wright Medical Group NV
Wright Medical Group NV Medical SpecialtiesHealth Technology Wright Medical Group NV engages in the provision of medical device products. It operates through the following segments: U.S. Lower Extremities and Biologics; U.S. Upper Extremities; International Extremities and Biologics; and Corporate. The U.S. Lower Extremities and Biologics includes the sale of its lower extremities products, such as joint implants and bone fixation devices for the foot and ankle; and biologics products used to support treatment of damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The U.S. Upper Extremities segment focuses on joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand; and products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries, and other ancillary products. The International Extremities and Biologics segment covers all lower and upper extremities products, as well as associated biologics products. The Corporate segment reflects general and administrative expenses not specifically associated with other segments. The company was founded by Frank O. Wright in 1950 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
Kyphon, Inc. |
- Börse
- Insiders
- Julie Dewey
- Erfahrung